← All organizations
Highest phase reached
Phase 3
First clinical trial
May 5, 2010Last known activity
Jul 31, 2019
Timeline
2010s
- May 5, 2010
Glycemic Index Laboratories, Inc— Founded
Drugs by trial phase (14 distinct, 14 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
Recent trials (25)
- NCT04019951Overall official - principal investigatorN/AJul 31, 2019
- NCT04019951CollaboratorN/AJul 31, 2019
- NCT03755232CollaboratorN/ADec 1, 2018
- NCT03755232Overall official - principal investigatorN/ADec 1, 2018
- NCT03660748CollaboratorEarly Phase 1Sep 14, 2018
- NCT03667963CollaboratorN/AAug 29, 2018
- NCT04820322Overall official - principal investigatorN/AAug 24, 2018
- NCT04820322CollaboratorN/AAug 24, 2018
- NCT04820322Reponsible party - principal investigatorN/AAug 24, 2018
- NCT03135015CollaboratorPhase 1Apr 26, 2017
- NCT03135015Overall official - principal investigatorPhase 1Apr 26, 2017
- NCT03165773Overall official - principal investigatorN/AAug 24, 2015
- NCT02801916Overall official - principal investigatorN/AApr 30, 2015
- NCT02801916Lead sponsorN/AApr 30, 2015
- NCT01939600CollaboratorN/ASep 30, 2013
Details
- Founded
- Los Angeles, CA, US May 5, 2010
- Last known activity
- Jul 31, 2019